Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK.

Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3893-7.

2.

Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation.

Fortun A, Khalil A, Gagné D, Douziech N, Kuntz C, Jay-Gerin JP, Dupuis G, Fülöp T Jr.

Atherosclerosis. 2001 May;156(1):11-21.

PMID:
11368992
3.

Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages.

Schrier RD, McCutchan JA, Wiley CA.

J Virol. 1993 Oct;67(10):5713-20.

4.

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.

J Neuroimmunol. 2005 Feb;159(1-2):155-64. Epub 2004 Dec 28.

PMID:
15652415
6.
7.

High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG.

J Exp Med. 1994 Feb 1;179(2):493-502.

8.

Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.

D'Orazio JA, Stein-Streilein J.

Clin Exp Immunol. 1996 May;104(2):366-73.

9.

Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.

Zhou X, Robertson AK, Rudling M, Parini P, Hansson GK.

Circ Res. 2005 Mar 4;96(4):427-34. Epub 2005 Jan 20.

10.
11.

Classification of CD4+ T helper cell clones in human melanoma.

Goedegebuure PS, Lee KY, Matory YL, Peoples GE, Yoshino I, Eberlein TJ.

Cell Immunol. 1994 Jun;156(1):170-9.

PMID:
7911074
12.

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.

Kan-Mitchell J, Huang XQ, Steinman L, Oksenberg JR, Harel W, Parker JW, Goedegebuure PS, Darrow TL, Mitchell MS.

Cancer Immunol Immunother. 1993 Jul;37(1):15-25.

PMID:
8513449
13.

Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

Nisini R, Paroli M, Accapezzato D, Bonino F, Rosina F, Santantonio T, Sallusto F, Amoroso A, Houghton M, Barnaba V.

J Virol. 1997 Mar;71(3):2241-51.

14.

Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.

Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M, Frank I, Trinchieri G.

J Exp Med. 1996 Jun 1;183(6):2559-69.

15.

In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cells.

Waldman WJ, Knight DA, Adams PW, Orosz CG, Sedmak DD.

Transplantation. 1993 Dec;56(6):1504-12.

PMID:
7904091
16.

Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.

Paroli M, Carloni G, Franco A, De Petrillo G, Alfani E, Perrone A, Barnaba V.

Immunology. 1994 Jun;82(2):215-21.

17.

Characterization of lidocaine-specific T cells.

Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, Pichler WJ.

J Immunol. 1997 Feb 1;158(3):1139-48.

PMID:
9013953
18.

T-lymphocytes and monocytes in atherogenesis.

Schmitz G, Herr AS, Rothe G.

Herz. 1998 May;23(3):168-77. Review.

PMID:
9646098
19.

Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules.

Mustafa AS, Shaban FA, Al-Attiyah R, Abal AT, El-Shamy AM, Andersen P, Oftung F.

Scand J Immunol. 2003 Feb;57(2):125-34.

20.

CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.

Lapointe R, Bellemare-Pelletier A, Housseau F, Thibodeau J, Hwu P.

Cancer Res. 2003 Jun 1;63(11):2836-43.

Supplemental Content

Support Center